14 Stocks That Jim Cramer Recently Talked About

5. Danaher Corporation (NYSE:DHR)

Number of Hedge Fund Holders In Q3 2024: 98

Danaher Corporation (NYSE:DHR) is a medical products company that supplies items to the biotechnology, diagnostics, and other industries. It also plays a key role in the bioprocessing industry, which is a sector thought to have considerable exposure to emerging and high-end medical industries such as gene editing and therapies. Danaher Corporation (NYSE:DHR)’s diagnostics and bioprocessing businesses, which have exposure to gene testing and drug discovery posted $2.36 billion and $1.78 billion in Q3 sales. Both of these beat analyst estimates but the stock tumbled by 11% following the earnings as its profit fell and the guidance failed to impress investors. Cramer is among those unimpressed by the direction Danaher Corporation (NYSE:DHR) is taking as he shared:

“The year-over-year from Danaher is terrible. They have not tried to stimulate where we thought they would, which is in medtech and in pharma. When are they going to take care of their people?”